Skip to main content
Log in

Lipoprotein Subfraction Profile and HDL-Associated Enzymes in Sickle Cell Disease Patients

  • Original Article
  • Published:
Lipids

Abstract

Although hypocholesterolemia is a reported finding in sickle cell disease (SCD), low-density lipoprotein (LDL)/high-density lipoprotein (HDL) subfractions and HDL-associated enzymes have not been determined in SCD patients. Blood was collected from 38 hemoglobin (Hb)A volunteers and 45 homozygous HbSS patients who had not received blood transfusions in the last 3 months. Serum lipids were measured by automated analyzer while LDL and HDL subfraction analysis was done by continuous disc polyacrylamide gel electrophoresis. Serum levels of cholesteryl ester transfer protein (CETP), lecithin-cholesterol acyltransferase (LCAT), apolipoprotein B (apoB) and apolipoprotein A-1 (apoA-I) were determined by enzyme-linked immunosorbent assay (ELISA). Total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) levels were significantly decreased, while TG levels were significantly increased in SCD patients compared to controls. A significant decrease in intermediate-density lipoprotein (IDL)-C, IDL-B, IDL-A and LDL-1 fractions were seen in SCD patients, while no significant difference was observed in small dense LDL particles. A significant decrease was seen in HDL-large, HDL-intermediate and HDL-small fractions in SCD patients versus controls. Levels of LCAT and ApoA-1 protein measured in SCD patients were significantly lower while no significant difference was observed in CETP and ApoB protein levels compared to controls. The reduction observed in LDL- and HDL-C in SCD patients was reflected as significantly decreased IDL, LDL-1 and HDL-subfractions. Decreased HDL subfractions may possibly lead to the reduced ApoA-1 and LCAT protein levels observed in SCD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

apoA-I:

Apolipoprotein A-1

apoB:

Apolipoprotein B

BMI:

Body mass index

CETP:

Cholesteryl ester transfer protein

CVD:

Cardiovascular disease

ELISA:

Enzyme-linked immunosorbent assay

Hb:

Hemoglobin

HbF:

Fetal Hb

HDL:

High-density lipoprotein

HDL-C:

High-density lipoprotein cholesterol

HRP:

Horseradish peroxidase

IDL-C:

Intermediate-density lipoprotein cholesterol

LCAT:

Lecithin-cholesterol acyltransferase

LDL:

Low-density lipoprotein

LDL-C:

Low-density lipoprotein cholesterol

VLDL:

Very-low-density lipoprotein cholesterol

mAb:

Monoclonal antibody

MID:

Middle

RBC:

Red blood cell

SCD:

Sickle cell disease

TC:

Total cholesterol

TMB:

Tetramethylbenzidine

References

  1. Aslan M, Freeman BA (2004) Oxidant-mediated impairment of nitric oxide signaling in sickle cell disease—mechanisms and consequences. Cell Mol Biol (Noisy-le-grand) 50(1):95–105

    CAS  Google Scholar 

  2. Aslan M, Freeman BA (2007) Redox-dependent impairment of vascular function in sickle cell disease. Free Radic Biol Med 43(11):1469–1483

    Article  PubMed  CAS  Google Scholar 

  3. Aslan M, Ryan TM, Adler B, Townes TM, Parks DA, Thompson JA, Tousson A, Gladwin MT, Patel RP, Tarpey MM, Batinic-Haberle I, White CR, Freeman BA (2001) Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci USA 98(26):15215–15220

    Article  PubMed  CAS  Google Scholar 

  4. Kupesiz A, Celmeli G, Dogan S, Antmen B, Aslan M (2012) The effect of hemolysis on plasma oxidation and nitration in patients with sickle cell disease. Free Radic Res 46(7):883–890

    Article  PubMed  CAS  Google Scholar 

  5. Aslan M, Canatan D (2008) Modulation of redox pathways in neutrophils from sickle cell disease patients. Exp Hematol 36(11):1535–1544

    Article  PubMed  CAS  Google Scholar 

  6. Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, Gladwin MT (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8(12):1383–1389

    Article  PubMed  CAS  Google Scholar 

  7. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM Jr, Gladwin MT (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 294(1):81–90

    Article  PubMed  CAS  Google Scholar 

  8. Hoppe C, Kuypers F, Larkin S, Hagar W, Vichinsky E, Styles L (2011) A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. Br J Haematol 153(5):655–663

    Article  PubMed  CAS  Google Scholar 

  9. Kato GJ, Gladwin MT (2008) Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. JAMA 300(22):2638–2646

    Article  PubMed  CAS  Google Scholar 

  10. Yuditskaya S, Tumblin A, Hoehn GT, Wang G, Drake SK, Xu X, Ying S, Chi AH, Remaley AT, Shen RF, Munson PJ, Suffredini AF, Kato GJ (2009) Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease. Blood 113(5):1122–1128

    Article  PubMed  CAS  Google Scholar 

  11. VanderJagt DJ, Shores J, Okorodudu A, Okolo SN, Glew RH (2002) Hypocholesterolemia in Nigerian children with sickle cell disease. J Trop Pediatr 48(3):156–161

    Article  PubMed  Google Scholar 

  12. Chapman MJ, Guérin M, Bruckert E (1998) Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Eur Heart J 19(Suppl A):A24–A30

    PubMed  CAS  Google Scholar 

  13. Asztalos BF, Cupples LA, Demissie S, Horvath KV, Cox CE, Batista MC, Schaefer EJ (2004) High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 24(11):2181–2187

    Article  PubMed  CAS  Google Scholar 

  14. Soran H, Hama S, Yadav R, Durrington PN (2012) HDL functionality. Curr Opin Lipidol 23(4):353–366

    Article  PubMed  CAS  Google Scholar 

  15. Sasaki J, Waterman MR, Buchanan GR, Cottam GL (1983) Plasma and erythrocyte lipids in sickle cell anaemia. Clin Lab Haematol 5(1):35–44

    Article  PubMed  CAS  Google Scholar 

  16. Aslan I, Kucuksayan E, Aslan M (2013) Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients. Lipids Health Dis 12:54

    Article  PubMed  CAS  Google Scholar 

  17. Aslan M, Ozcan F, Kucuksayan E (2013) Increased small dense LDL and decreased paraoxonase enzyme activity reveals formation of an atherogenic risk in streptozotocin-induced diabetic guinea pigs. J Diabetes Res 2013:860190

    PubMed  Google Scholar 

  18. Doğan S, Aslan I, Eryılmaz R, Ensari CO, Bilecik T, Aslan M (2013) Early postoperative changes of HDL subfraction profile and HDL-associated enzymes after laparoscopic sleeve gastrectomy. Obes Surg, Jun 14 [Epub ahead of print]

  19. Lagos KG, Filippatos TD, Tsimihodimos V, Gazi IF, Rizos C, Tselepis AD, Mikhailidis DP, Elisaf MS (2009) Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome. Lipids 44(1):9–16

    Article  PubMed  CAS  Google Scholar 

  20. Westerman MP (1975) Hypocholesterolaemia and anaemia. Br J Haematol 31(1):87–94

    Article  PubMed  CAS  Google Scholar 

  21. Zorca S, Freeman L, Hildesheim M, Allen D, Remaley AT, Taylor JG 6th, Kato GJ (2010) Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension. Br J Haematol 149(3):436–445

    Article  PubMed  CAS  Google Scholar 

  22. Marzouki ZM, Khoja SM (2003) Plasma and red blood cells membrane lipid concentration of sickle cell disease patients. Saudi Med J 24(4):376–379

    PubMed  Google Scholar 

  23. Akinyanju PA, Akinyanju CO (1976) Plasma and red cell lipids in sickle cell disease. Ann Clin Lab Sci 6(6):521–524

    PubMed  CAS  Google Scholar 

  24. Lulla RR, Thompson AA, Liem RI (2010) Elevated soluble transferrin receptor levels reflect increased erythropoietic drive rather than iron deficiency in pediatric sickle cell disease. Pediatr Blood Cancer 55(1):141–144

    PubMed  Google Scholar 

  25. Ngogang J, Mouray H, Lebreton de Vonne T, Raisonnier A (1989) Erythrocyte and plasma cholesterol exchange in sickle cell anemia. Clin Chim Acta 179(3):295–304

    Article  PubMed  CAS  Google Scholar 

  26. Erasmus RT, Olukoga AO, Ojuawo O (1990) Plasma lipids and lipoproteins in Nigerian children with sickle cell anemia. Ann Trop Paediatr 10(4):421–423

    PubMed  CAS  Google Scholar 

  27. Buchowski MS, Swift LL, Akohoue SA, Shankar SM, Flakoll PJ, Abumrad N (2007) Defects in postabsorptive plasma homeostasis of fatty acids in sickle cell disease. JPEN J Parenter Enteral Nutr 31(4):263–268

    Article  PubMed  CAS  Google Scholar 

  28. Gardner CD, Fortmann SP, Krauss RM (1996) Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276(11):875–881

    Article  PubMed  CAS  Google Scholar 

  29. Sasaki J, Waterman MR, Cottam GL (1986) Decreased apolipoprotein A-I and B content in plasma of individuals with sickle cell anemia. Clin Chem 32(1 Pt 1):226–227

    PubMed  CAS  Google Scholar 

  30. Fisher EA (2012) The degradation of apolipoprotein B100: multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathways. Biochim Biophys Acta 1821(5):778–781

    Article  PubMed  CAS  Google Scholar 

  31. Fielding CJ, Shore VG, Fielding PE (1972) A protein cofactor of lecithin:cholesterol acyltransferase. Biochem Biophys Res Commun 46(4):1493–1498

    Article  PubMed  CAS  Google Scholar 

  32. Emokpae MA, Uadia PO, Osadolor HB (2010) Lecithin:cholesterol acyltransferase, lipoprotein lipase and lipoproteins in adult Nigerians with Sickle cell disease. Afr J Biochem Res 4(2):17–20

    CAS  Google Scholar 

  33. Homan R, Esmaeil N, Mendelsohn L, Kato GJ (2013) A fluorescence method to detect and quantitate sterol esterification by lecithin:cholesterol acyltransferase. Anal Biochem 441(1):80–86

    Article  PubMed  CAS  Google Scholar 

  34. Savel J, Lafitte M, Pucheu Y, Pradeau V, Tabarin A, Couffinhal T (2012) Very low levels of HDL cholesterol and atherosclerosis, a variable relationship—a review of LCAT deficiency. Vasc Health Risk Manag 8:357–361

    PubMed  CAS  Google Scholar 

  35. Hammad SM, Stefansson S, Twal WO, Drake CJ, Fleming P, Remaley A, Brewer HB Jr, Argraves WS (1999) Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis. Proc Natl Acad Sci USA 96(18):10158–10163

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant (No.1204 U 0104) from the Mustafa Kemal University Research Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mutay Aslan.

About this article

Cite this article

Ozturk, O.H., Can, Y., Yonden, Z. et al. Lipoprotein Subfraction Profile and HDL-Associated Enzymes in Sickle Cell Disease Patients. Lipids 48, 1217–1226 (2013). https://doi.org/10.1007/s11745-013-3849-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11745-013-3849-4

Keywords

Navigation